David Allman

David Allman is a biochemist by training and has over 25 years of global experience in the pharmaceutical industry having worked for pharmaceutical companies and leading clinical research organizations as well as applying his expertise in the virtual development arena.

David has held a variety of roles in Hoffmann-La Roche, Quintiles, Fulcrum Pharma and Aptiv Solutions and more recently as one of the founder members of Artemida Pharma. He has worked on numerous development programmes including from entry-into-man through to successful NDAs in industry leading timeframes. He has led large project teams in all regions of the world, thus gaining invaluable experience in project oversight. Whilst the key focus has been in oncology development, David has also applied his development and programme management skills to several other therapeutic areas and compound types all of which have provided their unique challenges during development.